Mitral valve transcatheter edge-to-edge repair (MTEER) was approved in the United States for treatment of functional mitral regurgitation (FMR) based on results from the COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation) trial.
Each week, we present a journal club in which we choose a study that we believe will be of interest to the interventional cardiology community and discuss it at a virtual journal club with several of our faculty members.
Panelists
Presenter
